longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
Reuters
Oct 22, 2026 at 06:42 PM

Due to the copyright holder's request, this page is temporarily unavailable.

Recommended Readings

  • Moderna's personalized mRNA shot could reshape the fight against skin cancer - but it may also be overhypedAug 21, 2026 at 01:01 AM
  • Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA…Aug 20, 2026 at 03:29 AM
  • Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting ForAug 20, 2026 at 12:49 AM
  • Moderna's cancer-vaccine breakthrough drives broad biopharma stock rallyAug 20, 2026 at 12:28 AM
  • Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market TodayAug 19, 2026 at 05:10 PM

Related Stocks

Merck

USMRK

-1.34%

Merck

Merck

MRK.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy